LEXARIA BIOSCIENCE CORP. Cost of Goods Sold (Deprecated 2018-01-31)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $2.43 thousand for the 3-month period ending 2018-05-31, per its 10-Q filed 2018-07-13.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-07-13
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-05-31 was $2.43K, a 73.57% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $13.71K, a 7.79% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $6.10K, a 586.82% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $4.81K, a 78.97% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $29.75K, a 34.78% decline from fiscal 2016.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $45.62K, a 52.65% increase from fiscal 2015.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $29.88K.
- LEXARIA BIOSCIENCE CORP. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $0.00.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-05-31 | $2.43K 10-Q · filed 2018-07-13 | $16.14K derived: sum of 2 quarters · filed 2018-07-13 | $22.24K 10-Q · filed 2018-07-13 | $27.05K derived: sum of 4 quarters · filed 2018-07-13 |
| 2018-02-28 | $13.71K 10-Q · filed 2018-04-12 | $19.81K 10-Q · filed 2018-04-12 | $24.62K derived: sum of 3 quarters · filed 2018-04-12 | $33.80K derived: sum of 4 quarters · filed 2018-07-13 |
| 2017-11-30 | $6.10K 10-Q · filed 2018-01-12 | $10.91K derived: sum of 2 quarters · filed 2018-01-12 | $20.09K derived: sum of 3 quarters · filed 2018-07-13 | $34.96K derived: sum of 4 quarters · filed 2018-07-13 |
| 2017-08-31 | $4.81K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-27 | $13.99K derived: sum of 2 quarters · filed 2018-07-13 | $28.86K derived: sum of 3 quarters · filed 2018-07-13 | $29.75K 10-K · filed 2017-11-27 |
| 2017-05-31 | $9.18K 10-Q · filed 2018-07-13 | $24.05K derived: sum of 2 quarters · filed 2018-07-13 | $24.94K 10-Q · filed 2018-07-13 | $27.63K derived: sum of 4 quarters · filed 2018-07-13 |
| 2017-02-28 | $14.87K 10-Q · filed 2018-04-12 | $15.76K 10-Q · filed 2018-04-12 | $18.45K derived: sum of 3 quarters · filed 2018-01-12 | $27.75K derived: sum of 4 quarters · filed 2018-01-12 |
| 2016-11-30 | $888.00 10-Q · filed 2018-01-12 | $3.57K derived: sum of 2 quarters · filed 2018-01-12 | $12.88K derived: sum of 3 quarters · filed 2018-01-12 | $32.12K derived: sum of 4 quarters · filed 2018-01-12 |
| 2016-08-31 | $2.69K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-27 | $11.99K derived: sum of 2 quarters · filed 2017-11-27 | $31.23K derived: sum of 3 quarters · filed 2017-11-27 | $45.62K 10-K · filed 2017-11-27 |
| 2016-05-31 | $9.31K 10-Q · filed 2017-07-14 | $28.55K derived: sum of 2 quarters · filed 2017-07-14 | $42.93K 10-Q · filed 2017-07-14 | $61.07K derived: sum of 4 quarters · filed 2017-07-14 |
| 2016-02-29 | $19.24K 10-Q · filed 2017-04-14 | $33.62K 10-Q · filed 2017-04-14 | $51.76K derived: sum of 3 quarters · filed 2017-04-14 | $61.45K derived: sum of 4 quarters · filed 2017-04-14 |
| 2015-11-30 | $14.38K 10-Q · filed 2017-01-13 | $32.52K derived: sum of 2 quarters · filed 2017-01-13 | $42.21K derived: sum of 3 quarters · filed 2017-01-13 | $44.27K derived: sum of 4 quarters · filed 2017-01-13 |
| 2015-08-31 | $18.14K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $27.83K derived: sum of 2 quarters · filed 2016-11-29 | $29.88K derived: sum of 3 quarters · filed 2016-11-29 | $29.88K 10-K · filed 2016-11-29 |
| 2015-05-31 | $9.69K 10-Q · filed 2016-07-13 | $11.74K derived: sum of 2 quarters · filed 2016-07-13 | $11.74K 10-Q · filed 2016-07-13 | $11.74K derived: sum of 4 quarters · filed 2016-07-13 |
| 2015-02-28 | $2.05K 10-Q · filed 2016-04-13 | $2.05K 10-Q · filed 2016-04-13 | $2.05K derived: sum of 3 quarters · filed 2016-04-13 | $2.05K derived: sum of 4 quarters · filed 2016-04-13 |
| 2014-11-30 | $0.00 10-Q · filed 2016-01-08 | $0.00 derived: sum of 2 quarters · filed 2016-01-08 | $0.00 derived: sum of 3 quarters · filed 2016-01-08 | |
| 2014-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $0.00 derived: sum of 2 quarters · filed 2015-11-27 | $0.00 10-K · filed 2015-11-27 | |
| 2014-05-31 | $0.00 10-Q · filed 2015-07-14 | $0.00 10-Q · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |